An Uncharted Country
- 1 April 1999
- journal article
- editorial
- Published by Elsevier in Clinical Oncology
- Vol. 11 (2) , 71-72
- https://doi.org/10.1053/clon.1999.9016
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Guideline DocumentClinical Oncology, 1999
- Patient-reported short-term and long-term physical and psychologic symptoms: results of the continuous hyperfractionated accelerated [correction of acclerated] radiotherapy (CHART) randomized trial in non-small-cell lung cancer. CHART Steering Committee.Journal of Clinical Oncology, 1998
- Costs of conventional radical radiotherapy versus continuous hyperfractionated accelerated radiotherapy (CHART) in the treatment of patients with head and neck cancer or carcinoma of the bronchusClinical Oncology, 1997
- Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trialThe Lancet, 1997
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.Journal of Clinical Oncology, 1990